Burnham Asset Management’s GSK GSK Stock Holding History

Burnham Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,007	Closed	-$204K	–	211
2016 Q1	$204K	Sell	4,007 -80	-2%	-$3.98K	0.06%	199
2015 Q4	$206K	Sell	4,087 -80	-2%	-$4.08K	0.06%	206
2015 Q3	$200K	Sell	4,167 -80	-2%	-$4.16K	0.05%	212
2015 Q2	$221K	Sell	4,247 -215	-5%	-$12.1K	0.05%	212
2015 Q1	$257K	Sell	4,462 -400	-8%	-$22.9K	0.06%	204
2014 Q4	$260K	Sell	4,862 -160	-3%	-$8.95K	0.06%	214
2014 Q3	$289K	Buy	5,022 +240	+5%	+$14.7K	0.06%	204
2014 Q2	$320K	Sell	4,782 -160	-3%	-$10.8K	0.07%	207
2014 Q1	$330K	Sell	4,942 -160	-3%	-$10.8K	0.08%	203
2013 Q4	$340K	Hold	5,102	–	–	0.08%	198
2013 Q3	$320K	Hold	5,102	–	–	0.08%	204
2013 Q2	$319K	Buy	+5,102	New	+$324K	0.08%	197

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Burnham Asset Management's GSK Position: Q2 2016 in Review

Burnham Asset Management sold out of GSK (GSK) in Q2 2016, closing a stake of 4,007 shares — an estimated $204K sold.

Burnham Asset Management first reported a position in GSK in Q2 2013 and held it in 12 quarters. The position peaked at $340K in Q4 2013. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

Burnham Asset Management reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
Burnham Asset Management sold 4,007 GSK shares in Q2 2016, an estimated $204K.
Burnham Asset Management first reported a position in GSK in Q2 2013 and held it in 12 quarters.
Burnham Asset Management's GSK position peaked at $340K in Q4 2013.
741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.